Pulmonx Corporation (LUNG) vs Verrica Pharmaceuticals Inc. (VRCA)
A side-by-side comparison of Pulmonx Corporation and Verrica Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LUNG
Pulmonx Corporation
$1.77HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
VRCA
Verrica Pharmaceuticals Inc.
$4.26HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — LUNG vs VRCA
growth of $100 · dividends reinvested · last 6yLUNG -95.2% (-39.8%/yr)VRCA -94.7% (-38.6%/yr)VRCA compounded faster over this window
LUNG VRCA
LUNG vs VRCA: by the numbers
- •LUNG is the larger company ($75M vs $73M market cap).
- •Both run net losses; LUNG's is the smaller (-55.03% vs -102.84% net margin).
- •VRCA grew revenue faster over the past five years (20.37% vs 15.86% CAGR).
Metrics side by side
Valuation
| Metric | LUNG | VRCA |
|---|---|---|
| P/S ratio | 0.86 | 2.41 |
| P/B ratio | 1.91 | 16.97 |
Profitability
| Metric | LUNG | VRCA |
|---|---|---|
| Gross margin | 77.06% | 85.89% |
| Operating margin | -52.96% | -33.56% |
| Net margin | -55.03% | -102.84% |
| ROE | -122.76% | -724.01% |
| ROIC | -48.39% | -207.23% |
Growth (annualized)
| Metric | LUNG | VRCA |
|---|---|---|
| Revenue CAGR (5Y) | 15.86% | 20.37% |
| Total return CAGR (5Y) | -45.30% | -48.68% |
Frequently asked
- Which has grown faster, LUNG or VRCA?
- Over the past five years, VRCA grew revenue faster — LUNG at a 15.86% CAGR versus VRCA at 20.37%.
- How have LUNG and VRCA total returns compared?
- Over the past 5 years, LUNG delivered -45.30% and VRCA delivered -48.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pulmonx ROEVerrica Pharmaceuticals ROEPulmonx operating marginVerrica Pharmaceuticals operating marginPulmonx revenue growthVerrica Pharmaceuticals revenue growthPulmonx free cash flowVerrica Pharmaceuticals free cash flow
Pulmonx & Verrica Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.